Latest From Biotech Now

Stopping ALS: An interview with Dr. Perrin from ALS TDI

thumb

What is ALS? How widespread is the disease? Are there any treatments for ALS? Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease and outside the US as Motor Neuron Disease (MND) or Charcot’s Disease, is a progressive neurodegenerative disease that attacks motor neurons in the brain (upper motor neurons) and spinal cord (lower motor neurons) and affects muscle function. Dr. Steven Perrin is the CEO, CSO and Vice Chairman of the ALS Therapy Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , ,

State Deficits to Shrink & Taxes Drop – Good News for Biotech

Michigan State Capitol dome interior, Lansing, MI

Forecasters at the National Conference of State Legislatures’ 2011 Legislative Summit expect a dramatic reduction of state deficits in the coming years, along with business-friendly tax-cuts. The projections are based on a survey of budget officials in all 50 states last month, said Corina Eckl, director of state services for NCSL. Eckl also noted an emerging trend in which state governors and legislatures are allowing for the expiration of temporary business taxes. Notably, the Michigan Business Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Fall Preview: Business Development Events

Banner

Now that the Business Forum and International Convention are behind us, our Business Development department has been gearing up for a very busy Fall schedule.   The Line-Up For our first Fall event, BIO returns to India for its 2nd annual BIO India International Partnering Conference September 21st and 22nd.  Last year’s conference attracted more than 400 attendees representing 220 companies, from 17 countries around the world, – who scheduled over 750 meetings.  We’ve had Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Tech Transfer Summit North America

Tech Transfer Summit

The National Institutes of Health, BIO, and others are sponsoring the Tech Transfer Summit North America at NIH on 3-4 October 2011. Programming includes Translational Medicine & Funding Innovation, Successful Implementation of Biotech Innovation Strategies Worldwide, and Building Better Academia-Industry Collaborations: How will Big Pharma fill its early-stage Pipeline in 5 years’ time, among other topics. BIO’s President and CEO James C. Greenwood will give one keynote speach on the ”Barriers to Innovation in biotechnology, and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Raising the Stakes in Biotech

JimGreenwood

Small biotech companies continue to struggle to obtain funding as capital markets remain tight. The S&P downgrade may create even tighter credit markets and raise the cost of available credit, for small and large companies. To the extent that the downgrade leads capital flows out of the U.S., that hurts biotech. Biotech’s contributions to the world are critically needed. Our industry holds great promise for curing and treating many prevalent diseases, such as Alzheimer’s, cancer, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,